Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Towards an Open-Source Platform to Harmonize and Share Research Results from COVID-19 Interventional and Observational Studies.
1
Zitationen
3
Autoren
2023
Jahr
Abstract
As the SARS-CoV-2 virus continues to remain a universal threat on a global scale, a large number of COVID-19 clinical trials and observational studies are being conducted and published. Currently, 9,202 COVID-19 clinical trials have been registered on ClinicalTrials.gov and 293,187 COVID-19 articles were indexed in PubMed. To fully capitalize on the voluminous number of publications reporting COVID-19 interventional and observational studies, their results should be freely accessible via an open-source harmonized shared resource. We introduced ReMeDy (https://remedy.mssm.edu/), an intelligent integrative informatics platform aimed to harmonize and cross-link diverse COVID-19 trial outcomes and observational data. We tested the potential of the platform by uploading 52 COVID-19 clinical trials and 48 COVID-19 observational retrospective studies. ReMeDy was validated based on its capability to store and organize diverse data. The next steps include developing a crowdsourcing functionality coupled with automated outcome extraction using natural language processing.
Ähnliche Arbeiten
Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
2008 · 50.109 Zit.
Gene Ontology: tool for the unification of biology
2000 · 43.975 Zit.
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 · 18.843 Zit.
A translation approach to portable ontology specifications
1993 · 12.460 Zit.
Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research
2005 · 11.980 Zit.